All In MedTech

FDA Clearance Tracker · P090015

BOND ORACLE HER2 IHC SYSTEM

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Apr 18, 2012 (this decision)Source: openFDAMethods & limitations

PMA

The decision

FDA number
P090015
Device name
BOND ORACLE HER2 IHC SYSTEM
Applicant location
Danvers, MA
Received
Jul 22, 2009
Decided
Apr 18, 2012
Decision
Approved
Supplements
14 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code MVC

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE BOND ORACLE HER2 IHC SYSTEM. THIS DEVICE IS INDICATED FOR: BOND ORACLE HER2 IHC SYSTEM IS A SEMI-QUANTITATIVE IMMUNOHISTOCHEMICAL (IHC) ASSAY TO DETERMINE HER2 (HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2) ONCOPROTEIN STATUS IN FORMALIN-FIXED, PARRAFIN EMBEDDED BREAST CANCER TISSUE PROCESSED FOR HISTOLOGICAL EVALUATION FOLLOWING AUTOMATED STAINING ON THE BOND-MAX SLIDE STAINING INSTRUMENT. THE BOND ORACLE HER2 IHC SYSTEM IS INDICATED AS AN AID IN THE ASSESSMENT OF PATIENTS FOR WHOM HERCEPTIN (TRASTUZUMAB) TREATMENT IS BEING CONSIDERED.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MVC. The earliest in FDA's data is P980018, decided Sep 25, 1998.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Leica Biosystems

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.